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Aim: to determine patency after successful lysis of occluded bypass grafts.
Methods: data were collected from four centres with a wide experience of thrombolysis. Outcome following successful
lysis was determined from prospectively collected data or case notes. Data from 75 patients, 53 men, were analysed.
Results: median age at time of lysis was 68 years (range 33–88). Median age of graft was 12 months (range 1–120).
Patency at 12 months was 33% (95% conf. interval: 21–44%). There were no differences in patency depending on
whether the graft was above or below the inguinal ligament or whether an additional procedure eg. percutaneous or vein
patch angioplasty was carried out. However in those 48 cases when lysis was deemed complete, i.e. there was restoration
of graft patency and at least one vessel run off patency at 12 months was 39% compared with 17% if lysis was incomplete
(p=0.04).
Conclusions: at the present time it is difficult to justify routine thrombolysis of occluded grafts when patency, based on
intention to treat, is approximately 20% at one year. Following successful graft lysis the role of anticoagulation and
careful graft surveillance require further investigation.
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Introduction Bearing in mind the relatively high complication
rate graft thrombolysis can only be justified if long
A recent review suggested that intra-arterial throm- term patency after initial successful lysis were main-
tained. The aim of this study was to determine patencybolysis should be restricted to patients with graft
occlusions and those with short-duration ischaemia.1 following successful graft thrombolysis.
Successful lysis can be expected following graft oc-
clusions in approximately two thirds of cases.2,3 The
National Audit of Thrombolysis in Acute Leg Isch-
aemia (NATALI) database contains 421 episodes of
graft lysis. Complete lysis was achieved in 201 (48%) Patients and Methods
cases and partial lysis in 92 (22%). Thus successful
thrombolysis was achieved in 70% of lysis attempts Four centres were identified from the NATALI data-
(unpublished data). However, thrombolysis is as- base which had wide experience of graft thrombolysis
sociated with complications. Major haemorrhage oc- and who could provide data on follow up. NATALI
curs in 5% of cases, minor haemorrhage in 15% and only has results up to 30 days following treatment.
stroke in at least 1%.4 Clinical evidence of distal em- Outcome of patients having successful graft lysis was
bolisation has been reported in approximately 10% of determined from prospectively collected data sup-
cases.5 Sub-clinical, micro-emboli are probably even plemented if necessary by review of casenotes. In
more common whilst at the other end of the spectrum patients undergoing more than one episode of throm-
acute limb deterioration during thrombolysis due to bolysis only the first was analysed.
massive embolisation occurs in approximately 2% of Following discharge from hospital patients were
cases.6 seen routinely at six monthly intervals. They were
advised to contact the unit directly if symptoms sug-
∗ Please address all correspondence to: R. B. Galland, Consultant gestive of graft occlusion occurred. Patency was de-Surgeon, Royal Berkshire Hospital, London Road, Reading RG1
5AN. termined by clinical examination and calculation of
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Fig. 1. Overall patency. Fig. 2. Patency men compared with women.
Table 1. Initial management after re-occlusion.
• Conservative 19
• Operative
Thrombectomy and refashioning 5
Re-graft 10
Thrombectomy 1
• Repeat thrombolysis 8
• Amputation 6
Fig. 3. Patency complete compared with incomplete lysis.
Resultsankle brachial pressure indices. Duplex or angio-
graphy were carried out if clinically indicated. Vein
Overall patency, following initial successful throm-grafts underwent three monthly duplex surveillance.
A total of 75 patients, 53 men, were identified. Median bolysis, was 33% (95% CI: 21–44%) at 12 months and
27% (95% CI: 17–40%) at 18 months (Fig. 1). Sevenage of patient at time of thrombolysis was 68 years
(range 33–88 years). Median age of graft prior to patients died during the follow-up period. Treatment
following re-occlusion is shown in Table 1. Of theocclusion and thrombolysis was 12 months (range
1–120 months). There were 17 grafts above the inguinal eight patients undergoing further thrombolysis: five
grafts re-occluded within one month of treatment, oneligament (single limb of aortofemoral bifurcation graft
9, iliofemoral graft 5, femorofemoral cross over graft procedure was abandoned due to haematemesis and
two grafts remain patent at 33 and 60 months.2 and axillofemoral graft 1) and 58 grafts were below
the inguinal ligament (prosthetic grafts 47 and vein Patency, comparing men with women is shown in
Fig. 2. Although at all time points patency was greatergrafts 11).
In 27 cases a distal anastomotic stenosis was revealed with men this failed to reach statistical significance
(p=0.11). At 12 months patency was 38% vs 21%.by thrombolysis. These were treated with per-
cutaneous transluminal angioplasty in 20 cases and In 48 cases lysis was deemed complete. In other
words the graft was cleared along with at least onevein patch angioplasty in seven. In 48 cases no pro-
cedure was undertaken following thrombolysis. vessel run-off. In 27 cases patency was deemed in-
complete but clinically useful. Grafts with completelyFollowing successful thrombolysis 10 patients re-
ceived oral anticoagulation with warfarin. The re- restored patency had significantly improved long term
patency compared with those grafts where only partialmainder were placed on a daily regimen of 75 mg
aspirin. patency was achieved (p=0.04). At 12 months patency
was 37% vs 17%.Not included in this paper are indications for the
original graft, symptoms at occlusion, complications An additional procedure following lysis did not
result in an advantage in patency over one year, p=of thrombolysis and the type of agent and method
used for thrombolysis. 0.58, (Fig. 4). At 12 months patency was 29% vs 35%
in grafts with and without additional procedures,Patency was calculated by the Kaplan–Meier method
and differences compared by the log rank test. respectively.
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inguinal grafts,3 it could still be worth considering
lysis for these grafts, particularly in men.
These results also need to be balanced against mor-
bidity and mortality encountered with lysis. There is
some evidence that complications are higher with
thrombolysis of grafts compared with native arteries.
We found that acute limb deterioration, due to massive
embolisation, was approximately twice as likely in
patients undergoing graft thrombolysis compared with
those undergoing native artery treatment.6 In an ana-
lysis of more than 1000 patients in the NATALI data-
Fig. 4. Patency with or without an additional procedure. base haemorrhagic complications were also higher in
patients undergoing graft lysis.10
Patency following lysis did not differ between graft The STILE trial11 randomised patients to receive
sited above compared with below the inguinal liga- either thrombolysis or operation for the initial treat-
ment (p=0.20). ment of limb ischaemia. Comerata et al.8 analysed a
There was no difference in long-term patency de- subgroup of patients from that trial who had treatment
pending upon the age of the graft. For those 37 present for occluded grafts. Though the numbers were small
for less than one year 11 remained patent at 12 months there did appear to be an advantage in terms of lower
which compares with eight of 38 older grafts (N.S.). amputation rate for patients undergoing lysis rather
Similarly, the use of warfarin following the procedure than operation if ischaemia was of short duration (less
confirmed no advantage compared with aspirin alone. than 14 days). No such advantage was seen with longer
Of those patients taking warfarin four of ten grafts duration of ischaemia. Patients with grafts below the
were patent at one year. This compared with a one inguinal ligament had better results with operation
year patency of 15 of 65 grafts in patients taking aspirin than lysis at 30 days and 1-year. Morbidity was higher
(Chi-squared 0.57, df 1, N.S.). with attempted lysis of synthetic compared with vein
grafts.
In 27 of our cases an underlying stenosis was iden-
tified and treated. These patients fared no better thanDiscussion
those in whom an underlying lesion was not identified.
Others have described a higher incidence and treat-Our results show a one year patency following suc-
ment of underlying stenoses.7 However, overall pat-cessful graft lysis of only 33%. In approximately one
ency in that study (approximately 30% at one year)third of cases lysis is initially unsuccessful.2,3 This
was similar to ours. These authors also found thatcan be due to failure to place the catheter correctly,
patency was dependent upon the age of the graft.complications resulting in the procedure being pre-
Secondary patency was 21.5 months in grafts in placematurely ended or simply failure to lyse thrombus.
for more than one year compared with seven monthsThus, overall patency, based on intention to treat, is
for newer grafts. No such pattern was apparent in ourlikely to be about 20% at one year. Having identified
series.cases from the NATALI database we only analysed
If lysis is radiologically incomplete, even thoughdata from those centres who could provide accurate
there appears to be clinical benefit from lysis, longfollow up information. It might, therefore, be argued
term results are poor. In only 17% of such cases in ourthat 75 episodes of lysis described in this study may not
series was patency maintained at one year. Underbe representative of the group as a whole. However, the
these circumstances early graft replacement should beresults described showing an overall primary patency
considered.after successful thrombolysis of approximately 30%
Whether intensive surveillance, anticoagulation orare fairly typical of the results described in other
attempts to control intimal hyperplasia will help toseries.7–9
maintain patency after thrombolysis remains to beWe found that patency in men was higher than in
seen. However, at present once a graft has failed resultswomen but not significantly so. Similarly, long term
of salvage are poor. A recent series of attemptedpatency for grafts above the inguinal ligament was
surgical salvage of 40 occluded above knee prostheticgreater than that achieved for grafts below the inguinal
femoropopliteal bypasses described a one year patencyligament. Since the likelihood of immediate success
for thrombolysis may be higher compared with infra- of only 29%.11 The majority of these patients had
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